NRXS - Neuraxis, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.0 0.35 (11.67%) --- --- --- -0.03 (-1.0%) 0.26 (8.41%) --- -0.03 (-1.0%)

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Category: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.22
Diluted EPS:
-0.22
Basic P/E:
-15.2273
Diluted P/E:
-15.2273
RSI(14) 1m:
50.0
VWAP:
3.35
RVol:
4.0801

Events

Period Kind Movement Occurred At
1m Price decrease 1m 3.03 -0.06 (-1.94%) Oct 15 09:30
1m Price decrease 1m 2.97 -0.04 (-1.33%) Oct 15 07:16

Related News